Tenet Healthcare's (THC) stock soared 5.02% in intraday trading on Thursday, February 13, 2025, following the company's impressive fourth-quarter 2024 earnings report and upbeat 2025 guidance.
The healthcare services company reported fourth-quarter adjusted earnings per share of $3.44, surpassing analysts' estimates by 17.4% and its own guidance range. The strong quarterly performance was driven by higher same-hospital admissions, a favorable payer mix, increased Medicaid supplemental revenues, lower operating expenses, and facility buyouts and service line expansions in the Ambulatory Care unit.
For fiscal 2025, Tenet Healthcare provided robust guidance, projecting adjusted EBITDA growth of 7% at the midpoint, driven by anticipated growth in same-facility revenues, effective operational execution, and additional sites of care joining the Ambulatory Care portfolio. The company also expects continued strength in demand, high acuity growth, and further contributions from recent investments and partnerships in the Hospital segment.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。